Valuation : Roopa Industries Limited

Market Cap 308M 3.24M 2.79M 2.62M 2.39M 4.49M 4.52M 31.04M 12.08M 156M 12.16M 11.9M 518M P/E 2024
30.6x
P/E 2025 19.8x
Enterprise Value 607M 6.38M 5.49M 5.16M 4.71M 8.85M 8.91M 61.12M 23.78M 308M 23.96M 23.44M 1.02B EV / Sales 2024
0.97x
EV / Sales 2025 0.58x
Free-Float
36.13%
Yield 2024 *
-
Yield 2025 -
1 day-0.12%
1 week+3.34%
Current month-4.00%
1 month-0.04%
3 months-6.85%
6 months+2.35%
Current year+8.99%
1 week 47
Extreme 47
53.9
1 month 44.06
Extreme 44.06
53.9
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 38.1
Extreme 38.1
114.9
5 years 13.75
Extreme 13.75
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 1997-12-31
Director of Finance/CFO - 2020-06-30
Compliance Officer - 2022-05-31
Director TitleAgeSince
Chairman 72 1997-12-31
Director/Board Member 70 1997-03-16
Director/Board Member 70 2015-11-02
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+3.34%-15.70%+5.01% 3.96M
-1.52%-7.23%+57.90%+108.72% 1,047B
-0.82%-2.63%+50.05%+64.43% 646B
+0.37%-3.06%+21.87%+74.48% 451B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.59%-3.15%+49.83%+67.70% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.45%-0.27%+29.84%+91.34% 181B
Average -0.65%-2.27%+23.24%+44.27% 365.93B
Weighted average by Cap. -0.88%-3.94%+36.91%+64.77%

Financials

2024 2025
Net sales 714M 7.5M 6.46M 6.07M 5.54M 10.4M 10.48M 71.87M 27.96M 362M 28.17M 27.56M 1.2B 1.21B 12.73M 10.96M 10.3M 9.4M 17.65M 17.78M 122M 47.47M 614M 47.81M 46.77M 2.03B
Net income 15.19M 160K 137K 129K 118K 221K 223K 1.53M 595K 7.7M 599K 586K 25.51M 20.35M 214K 184K 173K 158K 296K 299K 2.05M 797K 10.32M 803K 786K 34.17M
Net Debt 228M 2.39M 2.06M 1.93M 1.77M 3.32M 3.34M 22.93M 8.92M 115M 8.99M 8.79M 382M 299M 3.14M 2.7M 2.54M 2.32M 4.35M 4.39M 30.09M 11.71M 152M 11.79M 11.54M 502M
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
51
Date Price Change Volume
26-08-31 ₹48.00 -0.12% 142
26-08-28 ₹48.06 -3.49% 888
26-08-27 ₹49.80 -4.96% 1,875
26-08-26 ₹52.40 +2.75% 50
26-08-25 ₹51.00 +0.28% 872
  1. Stock Market
  2. Stocks
  3. 530991 Stock